Abstract
Tuberculosis subunit vaccines codelivered with interleukin-12 (IL-12)-encapsulated microspheres (IL-12EM) are designed for a sustained release of IL-12 and could induce strong Th1 immune responses specific to Ag85A and ESAT-6. The adjuvant combination of IL-12EM plus AS01B was a more efficient way to induce a sustained Th1 immunity and protection against Mycobacterium tuberculosis.
Original language | English |
---|---|
Pages (from-to) | 4954-4959 |
Number of pages | 6 |
Journal | Infection and Immunity |
Volume | 74 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2006 Aug |
All Science Journal Classification (ASJC) codes
- Parasitology
- Microbiology
- Immunology
- Infectious Diseases